Access to allergy care: implications for quality healthcare and public safety.

Managed care quarterly

Volumn 11, Issue 2, 2003, Pages 8-11

  Berger, William E ^a   Rosenwasser, Lanny ^a   Atwater, J Spencer ^a  

^a Southern California Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST;

ARTICLE; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; INSURANCE; ORGANIZATION AND MANAGEMENT; PERENNIAL RHINITIS; POLICY; PRESCRIPTION; SAFETY; UNITED STATES;

ANTI-ASTHMATIC AGENTS; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INSURANCE COVERAGE; MANAGED CARE PROGRAMS; ORGANIZATIONAL POLICY; PRESCRIPTIONS, DRUG; QUALITY OF HEALTH CARE; RHINITIS, ALLERGIC, PERENNIAL; SAFETY MANAGEMENT; UNITED STATES;

EID: 0242304824     PISSN: 10645454     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)